You are here: Industry Insights > SAGE

News List

A Second 'Closet' for Some LGBTQ Seniors Entering Nursing Homes drugs
August 11, 2021
The Stonewall generation is entering old age, and a new study finds many LGBTQ+ seniors are fearful that the prejudices of staff and fellow residents at nursing homes could leave them vulnerable to continued misunderstanding, stigma and discrimination.
UK scientists believe it is 'almost certain' a coronavirus variant will emerge that beats current vaccines firstwordpharma
August 02, 2021
An analysis published by the UK government's Scientific Advisory Group for Emergencies (SAGE) says they believe it is "almost certain" that a SARS-Cov-2 variant will emerge that "leads to current vaccine failure," CNN reported Sunday.
Sage wins OK for depression drug Zulresso fiercepharma
March 20, 2019
Up next? Major marketing challenges
FDA panel backs Sage’s novel antidepressant but turns down Alkermes’ pharmaphorum
December 14, 2018
Sage’s Zulresso (brexanolone) is on course for approval for postnatal depression in the US after a positive vote from an FDA advisory committee at its meeting last week, but the same panel had bad news for Alkermes’ two-drug therapy....
Sage soars as postpartum depression phase 3 trials hit goals fiercebiotech
November 10, 2017
Sage Therapeutics’ brexanolone has cleared the bar of efficacy in two phase 3 trials in women with postpartum depression (PPD).